Veterinary Medicines

Linco-Sol 400 mg/g Powder for Use in Drinking Water for Pigs and Chickens

Authorised
  • Lincomycin
Download as PDF

Product identification

Medicine name:
Linco-Sol 400 mg/g powder for use in drinking water for pigs and chickens
Linco-Sol 400 mg/g Powder for Use in Drinking Water for Pigs and Chickens
Active substance:
  • Lincomycin
Target species:
  • Pig
  • Chicken (broiler)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Lincomycin
    400.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        1
        day
    • Chicken (broiler)
      • Meat and offal
        5
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • 1.5 kg polypropylene container with polypropylene lid and inner bag of LDPE.
  • 5 kg polypropylene container with polypropylene lid and inner bag of LDPE.
  • 150 g polypropylene container with polypropylene lid and inner bag of LDPE.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lavet Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lavet Kft.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 32823/4005
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0111/001
Concerned member states:
  • Czechia
  • Germany
  • Greece
  • Italy
  • Lithuania
  • Poland
  • Portugal
  • Romania
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."